Two mutations in the HSN2 gene explain the high prevalence of HSAN2 in French Canadians
- 24 May 2005
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Neurology
- Vol. 64 (10), 1762-1767
- https://doi.org/10.1212/01.wnl.0000161849.29944.43
Abstract
Background: Hereditary sensory and autonomic neuropathy type 2 (HSAN2; MIM 201300) is a rare recessive neuropathy typically diagnosed in the first decade. The 1973 study of a French Canadian family led to the definition of HSAN2. Objectives: To demonstrate that the apparent higher prevalence of HSAN2 in Quebec is due to the presence of two HSN2 mutations and that carriers of different mutations appear to have a similar phenotype. Methods: Through attending physicians, the authors recruited French Canadian patients with HSAN2. Exclusion of linkage to the known HSAN loci and linkage to the HSAN2 was performed using standard methods. Sequencing of the HSN2 gene was used to uncover the causal mutations. Results: A large cluster of HSAN2 patients comprising 16 affected individuals belonging to 13 families was identified. The mode of inheritance is clearly autosomal recessive. All patients originated from southern Quebec, and 75% are from the Lanaudière region. Whereas linkage to the HSAN1, 3, and 4 loci was excluded, linkage to the 12p13.33 HSAN2 locus was confirmed. Sequencing of the HSN2 gene uncovered two French Canadian mutations and a novel nonsense mutation in a patient of Lebanese origin, all predicted to lead to truncations of the HSN2 protein. The comparison of clinical variables between patients with different genotypes does not suggest any difference in phenotype. Conclusions: Two founder mutations are responsible for the apparently higher prevalence of HSAN2 in French Canadians. Genotype-phenotype correlation does not suggest any significant clinical variability.Keywords
This publication has 30 references indexed in Scilit:
- A mutation in the HSN2 gene causes sensory neuropathy type II in a Lebanese familyAnnals of Neurology, 2004
- A mutation in the nerve growth factor beta gene (NGFB) causes loss of pain perceptionHuman Molecular Genetics, 2004
- The K–Cl cotransporter KCC3 is mutant in a severe peripheral neuropathy associated with agenesis of the corpus callosumNature Genetics, 2002
- Familial Dysautonomia Is Caused by Mutations of the IKAP GeneAmerican Journal of Human Genetics, 2001
- ARSACS, a spastic ataxia common in northeastern Québec, is caused by mutations in a new gene encoding an 11.5-kb ORFNature Genetics, 2000
- Congenital Insensitivity to Pain with Anhidrosis: Novel Mutations in the TRKA (NTRK1) Gene Encoding A High-Affinity Receptor for Nerve Growth FactorAmerican Journal of Human Genetics, 1999
- Mutations in the TRKA/NGF receptor gene in patients with congenital insensitivity to pain with anhidrosisNature Genetics, 1996
- The gene for hereditary sensory neuropathy type I (HSN–I) maps to chromosome 9q22.1–q22.3Nature Genetics, 1996
- Localization of the gene for familial dysautonomia on chromosome 9 and definition of DNA markers for genetic diagnosisNature Genetics, 1993
- The Nerve Growth Factor 35 Years LaterScience, 1987